Levolta Pharmaceuticals, founded in 2013 and headquartered in Bethlehem, Pennsylvania, is a clinical-stage pharmaceutical company specializing in developing enhanced therapeutics for rheumatology, immunology, and oncology. Their lead product, VOLT01, is a proprietary derivative of zoledronic acid aimed at improving efficacy and reducing side effects in treating conditions like osteoarthritis.